Related references
Note: Only part of the references are listed.The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels A Retrospective Multicenter Cohort Study
Mohammad Hosein Aziz et al.
ANNALS OF SURGERY (2019)
Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer
Jian-Xian Lin et al.
GASTRIC CANCER (2019)
Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer
Yan Wang et al.
EBIOMEDICINE (2019)
Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer
Yasuhito Suenaga et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
Jian-Xian Lin et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Shumei Kato et al.
CLINICAL CANCER RESEARCH (2018)
Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer
Yoshiyuki Suzuki et al.
ANNALS OF SURGERY (2018)
Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy
Hiroaki Uda et al.
DIGESTIVE SURGERY (2018)
Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients
Wei Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma
Sam C. Wang et al.
ANNALS OF SURGERY (2016)
Prediction models need appropriate internal, internal-external, and external validation
Ewout W. Steyerberg et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Prognostic Value of Early Postoperative Tumor Marker Response in Gastric Cancer
Dong Hyuk Nam et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
High level of preoperative carbohydrate antigen 19-9 is a poor survival predictor in gastric cancer
A. Ra Choi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy
Hidenori Toyoda et al.
JOURNAL OF HEPATOLOGY (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2010)
Serum Carcinoembryonic Antigen Monitoring After Curative Resection for Colorectal Cancer: Clinical Significance of the Preoperative Level
In Ja Park et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
Cristina R. Ferrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Utility of tumor markers in determining resectability of pancreatic cancer
MG Schlieman et al.
ARCHIVES OF SURGERY (2003)
Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer
D Marrelli et al.
JOURNAL OF SURGICAL ONCOLOGY (2001)
Share Paper
